LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.95 | 770.25 | 1432 | 1832 | 0.7815 | 0.6420 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 18.95 | 770.25 | 1818 | 1832 | 0.9921 | 0.9873 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 21.17 | 770.25 | 1457 | 2008 | 0.7255 | 0.5857 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 21.17 | 770.25 | 1856 | 2008 | 0.9241 | 0.8891 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 23.39 | 770.25 | 1565 | 2244 | 0.6973 | 0.5832 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 23.39 | 770.25 | 1963 | 2244 | 0.8746 | 0.8336 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 25.62 | 770.25 | 1750 | 2514 | 0.6959 | 0.6173 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 25.62 | 770.25 | 2186 | 2514 | 0.8692 | 0.8424 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.84 | 770.25 | 1907 | 2833 | 0.6729 | 0.6199 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 27.84 | 770.25 | 2494 | 2833 | 0.8801 | 0.8686 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 30.06 | 770.25 | 2041 | 3106 | 0.6571 | 0.6232 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 30.06 | 770.25 | 2811 | 3106 | 0.9050 | 0.9032 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 32.28 | 770.25 | 2284 | 3392 | 0.6732 | 0.6622 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 32.28 | 770.25 | 3007 | 3392 | 0.8863 | 0.8902 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 34.50 | 770.25 | 2552 | 3712 | 0.6875 | 0.6955 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 34.50 | 770.25 | 3233 | 3712 | 0.8710 | 0.8818 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.73 | 770.25 | 2760 | 4086 | 0.6755 | 0.6992 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.73 | 770.25 | 3496 | 4086 | 0.8556 | 0.8745 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.95 | 770.25 | 3026 | 4543 | 0.6660 | 0.7064 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.95 | 770.25 | 3895 | 4543 | 0.8572 | 0.8832 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.17 | 770.25 | 3379 | 5010 | 0.6744 | 0.7286 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.17 | 770.25 | 4369 | 5010 | 0.8720 | 0.9011 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 43.39 | 770.25 | 3664 | 5404 | 0.6780 | 0.7417 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 43.39 | 770.25 | 4800 | 5404 | 0.8882 | 0.9174 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 45.61 | 770.25 | 3959 | 5813 | 0.6811 | 0.7532 | MN20160304_L02 | H17 |